Company: BGLC
Filing Date: 2025-11-07
Form Type: S-3
Source: 0001477932-25-007976
Chunk: 4

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-07
Form: S-3
Chunk 4
---
 of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is ______, 2025</div>

| iii |

<div align='center'>TABLE OF CONTENTS</div>

|                                                                                     |     | Page |
| ABOUT THIS PROSPECTUS                                                               |     |    1 |
| WHERE YOU CAN FIND MORE INFORMATION                                                 |     |    2 |
| INFORMATION WE INCORPORATE BY REFERENCE                                             |     |    3 |
| SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS                                   |     |    4 |
| BioNexus Gene Lab Corp.                                                             |     |    5 |
| RISK FACTORS                                                                        |     |    7 |
| USE OF PROCEEDS                                                                     |     |    7 |
| DESCRIPTION OF CAPITAL STOCK                                                        |     |    7 |
| DESCRIPTION OF WARRANTS                                                             |     |   10 |
| DESCRIPTION OF RIGHTS                                                               |     |   11 |
| DESCRIPTION OF UNITS                                                                |     |   12 |
| PLAN OF DISTRIBUTION                                                                |     |   13 |
| LEGAL MATTERS                                                                       |     |   15 |
| EXPERTS                                                                             |     |   15 |
| DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES |     |   16 |

| iv |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This prospectus is part of a Registration Statement on Form S-3 that we filed with the Securities and Exchange Commission, or the SEC, using a “shelf” registration or continuous offering process. Under this shelf registration process, we may, from time to time, sell any combination of the securities described in this prospectus in one or more offerings up to a total aggregate offering price of $100,000,000.

This prospectus provides a general description of the securities we may offer. Each time we sell securities, we will, to the extent required, provide a prospectus supplement containing specific information about the terms of that offering and the securities being offered. We may provide specific terms of securities to be offered in one or more supplements to this prospectus. We may also provide a specific plan of distribution for any securities to be offered in a prospectus supplement. Prospectus supplements may also add, update or change information in this prospectus. If the information varies between this prospectus and the accompanying